. . . "1213-0494" . "http://www.medvik.cz/link/bmc11010093" . "12" . "invasive fungal infection; antifungal agents; yeasts; koles; children"@en . . . "Invasive fungal infection: application of antifungal drugs in pediatric practice"@en . . "Sedl\u00E1\u010Dek, Petr" . . "CZ - \u010Cesk\u00E1 republika" . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED: pou\u017Eit\u00ED antimykotik v pediatrick\u00E9 praxi"@cs . . . "Keslov\u00E1, Petra" . . . "Invasive fungal infection: application of antifungal drugs in pediatric practice"@en . "3"^^ . . "RIV/00064203:_____/11:7248" . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED: pou\u017Eit\u00ED antimykotik v pediatrick\u00E9 praxi" . "3"^^ . "Chrenkov\u00E1, Vanda" . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED: pou\u017Eit\u00ED antimykotik v pediatrick\u00E9 praxi"@cs . . "2" . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED (IFI) jsou i nad\u00E1le p\u0159\u00ED\u010Dinou morbidity a mortality novorozenc\u016F, imunosuprimovan\u00FDch i imunokompetentn\u00EDch d\u011Bt\u00ED. P\u0159esto\u017Ee tyto infekce jsou dob\u0159e charakterizov\u00E1ny v dosp\u011Bl\u00E9 populaci, incidence, diagnostick\u00E9 postupy, anal\u00FDzy rizikov\u00FDch faktor\u016F a terapeutick\u00E9 v\u00FDsledky nejsou st\u00E1le u d\u011Bt\u00ED dostate\u010Dn\u011B prozkoum\u00E1ny. Nad\u00E1le z\u016Fst\u00E1vaj\u00ED nedo\u0159e\u0161eny i probl\u00E9my kolem \u00FA\u010Dinnosti, bezpe\u010Dnosti a spr\u00E1vn\u00E9ho d\u00E1vkov\u00E1n\u00ED \u0159ady ji\u017E b\u011B\u017En\u011B pou\u017E\u00EDvan\u00FDch antimykotik u d\u011Bt\u00ED r\u016Fzn\u00FDch v\u011Bkov\u00FDch kategori\u00ED. V \u010Dl\u00E1nku bychom cht\u011Bli stru\u010Dn\u011B prezentovat, co nov\u00E9ho bylo v t\u00E9to specifick\u00E9 oblasti pediatrie publikov\u00E1no v roce 2010 a citov\u00E1no v datab\u00E1zi PubMed." . "Invasive fungal infection (IFI) continues to be frequent cause of morbidity and mortality in neonates and in both immunocompromised and immunocompetent children. Although these infections have been well characterized in adults, incidence, diagnostic tools, analysis of risk factors and treatment outcomes have not been well described in children. Data regarding the efficacy, safety and proper dosing of widely used antifungals in children of different age categories still remain to be solved. In this paper we would like to summarize news published about this specific topic of pediatrics over year 2010 and excerpted in PubMed database."@en . . . . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED: pou\u017Eit\u00ED antimykotik v pediatrick\u00E9 praxi" . . "Invazivn\u00ED mykotick\u00E1 onemocn\u011Bn\u00ED (IFI) jsou i nad\u00E1le p\u0159\u00ED\u010Dinou morbidity a mortality novorozenc\u016F, imunosuprimovan\u00FDch i imunokompetentn\u00EDch d\u011Bt\u00ED. P\u0159esto\u017Ee tyto infekce jsou dob\u0159e charakterizov\u00E1ny v dosp\u011Bl\u00E9 populaci, incidence, diagnostick\u00E9 postupy, anal\u00FDzy rizikov\u00FDch faktor\u016F a terapeutick\u00E9 v\u00FDsledky nejsou st\u00E1le u d\u011Bt\u00ED dostate\u010Dn\u011B prozkoum\u00E1ny. Nad\u00E1le z\u016Fst\u00E1vaj\u00ED nedo\u0159e\u0161eny i probl\u00E9my kolem \u00FA\u010Dinnosti, bezpe\u010Dnosti a spr\u00E1vn\u00E9ho d\u00E1vkov\u00E1n\u00ED \u0159ady ji\u017E b\u011B\u017En\u011B pou\u017E\u00EDvan\u00FDch antimykotik u d\u011Bt\u00ED r\u016Fzn\u00FDch v\u011Bkov\u00FDch kategori\u00ED. V \u010Dl\u00E1nku bychom cht\u011Bli stru\u010Dn\u011B prezentovat, co nov\u00E9ho bylo v t\u00E9to specifick\u00E9 oblasti pediatrie publikov\u00E1no v roce 2010 a citov\u00E1no v datab\u00E1zi PubMed."@cs . "4"^^ . "I, Z(MZ0FNM2005)" . . "205643" . "[E53CF1A52A70]" . "RIV/00064203:_____/11:7248!RIV12-MZ0-00064203" . . . "Pediatrie pro praxi" . .